LAUSANNE, Switzerland--(BUSINESS WIRE)--Sep. 6, 2016--
Philip Morris International Inc. (NYSE/Euronext Paris: PM) today
releases the first Reduced-Risk Product (RRP) Scientific Update, a
regular publication on its research efforts to develop and assess a
range of potentially reduced-risk alternatives to cigarettes. The report
is available at http://www.pmi.com/eng/media_center/press_releases/Documents/PMI%20Scientific%20Update%20Sept%202016.pdf.
The Update is meant to provide scientists, regulators and others a
summary of PMI’s product development and assessment approach as well an
overview of the latest studies, key peer-reviewed publications and
presentations at scientific conferences. It is an important complement
to PMI’s ongoing efforts to share its latest science, which include a
dedicated website (www.pmiscience.com).
Prof. Manuel Peitsch, PMI’s Chief Scientific Officer, explains: “We
are making significant efforts to develop and scientifically assess
innovative products that generate a vapor in which harmful chemicals
found in cigarette smoke are significantly reduced or eliminated while
the taste, sensory experience and ritual characteristics of smoking are
preserved as much as possible. Along with many public health experts, we
believe innovative products backed up by solid science can play an
important role to reduce the harm of smoking. Sharing our methodologies
and findings allows feedback and review from external experts and
regulators and can encourage further research in the field.”
PMI’s extensive research is inspired by the well-recognized practices of
the pharmaceutical industry and in line with guidance of the U.S. FDA
for Modified-Risk Tobacco Products (MRTPs). The Company today employs
over 300 world-class scientists who conduct rigorous research, including
laboratory and clinical studies, as well as ground-breaking systems
toxicology. The assessment program also includes studies on actual
product use and correct understanding of product communications, as well
as post-market research.
Michele Cattoni, PMI’s VP Technology and Operations, further elaborates
on the Company’s efforts: “Technological innovation is transforming
our industry with a wide range of noncombustible nicotine products that
have the potential to represent significantly reduced-risk alternatives
compared to smoking. PMI has been, and will continue to be, a driving
force in this transformation. Our ambition is that ultimately
reduced-risk alternatives replace cigarettes to the benefit of smokers,
society and our company.”
###
Philip Morris International Inc.
Philip Morris International Inc. (PMI) is the world’s leading
international tobacco company, with six of the world's top 15
international brands and products sold in more than 180 markets. In
addition to the manufacture and sale of cigarettes, including Marlboro,
the number one global cigarette brand, and other tobacco products, PMI
is engaged in the development and commercialization of Reduced-Risk
Products (“RRPs”). RRPs is the term PMI uses to refer to products with
the potential to reduce individual risk and population harm in
comparison to smoking cigarettes. Through multidisciplinary capabilities
in product development, state-of-the-art facilities, and
industry-leading scientific substantiation, PMI aims to provide an RRP
portfolio that meets a broad spectrum of adult smoker preferences and
rigorous regulatory requirements. For more information, see www.pmi.com and www.pmiscience.com.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160906005606/en/
Source: Philip Morris International
Media enquiries
Philip Morris International media office
T:
+41 (0)58 242 4500
E: media@pmi.com
